MDxHealth SA - Company Profile
Powered by 
All the sales intelligence you need on MDxHealth SA in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how MDxHealth SA fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with MDxHealth SA.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on MDxHealth SA patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20220396842A1 | Application | METHOD FOR USING GENE EXPRESSION TO DETERMINE PROGNOSIS OF PROSTATE CANCER | C12Q1/6886; C12Q2600/118; C12Q2600/158; C12Q2600/178 | December 15, 2022 |
| US20210246515A1 | Application | COMBINATION OF mRNA EXPRESSION LEVELS OF DLX1 AND HOXC6 IN URINE AS MOLECULAR MARKERS IN PROSTATE CANCER | C12Q1/6886; C12Q2600/112; C12Q2600/158 | August 12, 2021 |
| EP3596236B1 | Grant | EPIGENETISCHER MGMT-TIEFENSEQUENZTEST | C12Q1/6886; C12Q2600/106; C12Q2600/154 | June 02, 2021 |
| CA2858144C | Grant | METHODS OF DETECTING MUTATIONS AND EPIGENETIC CHANGES | C12Q1/6858; C12Q1/6881; C12Q1/6886; C12Q2600/154; C12Q2600/156 | May 04, 2021 |
| CA2901120C | Grant | METHODS AND KITS FOR IDENTIFYING AND ADJUSTING FOR BIAS IN SEQUENCING OF POLYNUCLEOTIDE SAMPLES | C12Q1/6869; C12Q1/6874; C12Q2600/154; C12Q2600/156 | May 04, 2021 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer